ABLAVAR (www.ABLAVAR.com) is a web site for FDA-approved ABLAVAR (gadofoveset trisodium), the first FDA-approved gadolinium (Gd)-based blood-pool contrast agent for MRA. ABLAVAR is currently marketed by Lantheus Medical Imaging, Inc. The ABLAVAR web site